:: Volume 23, Issue 2 (Scientific Journal of Kurdistan University of Medical Sciences 2018) ::
SJKU 2018, 23(2): 12-20 Back to browse issues page
Evaluation of the survival rate and its related factors in patients with leukemia in Kurdistan Province
Ghobad Moradi Dr * 1, Mohammad Aziz Rasouli 2, Faez Fathi 3, Bayazid Ghaderi Dr4, Bahram Nikkhoo Dr5, Daem Roshani Dr6, Borhan Moradvaisi Dr7, Jafar Soltani Dr8
1- Associated Professor Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran , moradi_gh@yahoo.com
2- Department of Epidemiology and Biostatistics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
4- Assistant Professor Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
5- Associated Professor Department of Pathology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
6- Associated Professor Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
7- Assistant Professor Department of Pediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
8- Associated Professor Department of Pediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences
Abstract:   (221 Views)
Background and Aim: In recent decades, the survival rates of the children with cancer have improved significantly and their five-year survival rates have reached 80%, but there are still many concerns about the survival of adolescents and young people.
Methods and Materials: In this retrospective study, the data of 310 children and adults with leukemia in Kurdistan Province were extracted from their medical records. Univariate and multivariate survival analysis were performed through calculating hazard ratios using Cox relative risk model. Data analysis was carried out using Stata 12 software.
Results: This study included 201 adults with mean age of 50.8 years and 109 children with mean age of 5.2 years. The frequency of AML was higher in the adults (30.8%), while the frequency of ALL cases was higher in the children (86.2%). The respective one-year and five-year survival rates, were 94.4% and 49.5% in the adults, and 92.6% and 83% in the children. The hazard ratios (HR) were 5.18 (95% CI: 2.60-13) in the adults with ALL and 4.11 (95% CI: 1.55-10.4) in the adults with AML, and 2.78 (95% CI: 1.05-7.37) in the patients with CML. Based on the results of multivariate analysis, the rate of mortality in children with ALL was lower (HR=0.26, 95% CI: 0.08-0.77).
Conclusion: Timely diagnosis and provision of treatment services for the patients are recommended. Considering the high rate of survival in the patients with ALL especially in children, we recommend provision of appropriate treatment facilities and palliative care services, similar to those in other countries, for the patients with different types of leukemia with high rates of mortality.
Keywords: Survival rate, Related factors, Leukemia, Children, Adults, Kurdistan.
 
Received: Apr 26, 2017     Accepted: Feb 12, 2018 
Keywords: Survival rate, Related factors, Leukemia, Children, Adults, Kurdistan.
Full-Text [PDF 595 kb]   (93 Downloads)    
Type of Study: Research | Subject: General
Received: 2018/05/31 | Accepted: 2018/05/31 | Published: 2018/05/31
References
1. 1. Xu Z, Zhou H, Lei L, Li H, Yu W, Fu Z, et al. Incidence of Cancer in Shenzhen, Guangdong Province during 2001–2015: A Retrospective Population-Based Study. Int J Environ Res Public Health 2017; 14: 1137. [DOI:10.3390/ijerph14101137]
2. Reis RS, Silva NP, Santos MO, Oliveira JFP, Thuler LCS, de Camargo B, et al. Mother and child characteristics at birth and early age leukemia: a case-cohort population-based study in Brazil. J Pediatr (Rio J) 2017; 93: 610-18. [DOI:10.1016/j.jped.2016.12.009]
3. Ou JY, Smits-Seemann RR, Kaul S, Fluchel MN, Sweeney C, Kirchhoff AC. Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample. J Cancer Epidemiol 2017; 49: 216-24. [DOI:10.1016/j.canep.2017.06.005]
4. Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B. Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014). Medicine 2017; 96: e5941. [DOI:10.1097/MD.0000000000005941]
5. Pole JD, Darmawikarta D, Alibhai SM, Brandwein JM, Sung L. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia. Leuk Res 2013; 37: 1258-64. [DOI:10.1016/j.leukres.2013.05.001]
6. Wolfson J, Sun CL, Wyatt L, Stock W, Bhatia S. Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome. Cancer Epidemiol Biomarkers Prev 2017; 26: 312-20. [DOI:10.1158/1055-9965.EPI-16-0722]
7. Wolfson JA. Piecing together the puzzle of disparities in adolescents and young adults. Cancer 2015; 121: 1168-71. [DOI:10.1002/cncr.29193]
8. Kleinbaum DG, Klein M. Survival analysis: a self-learning text. 3nd ed. New York: Springer Science & Business Media, 2006: 1-201.
9. Ayremlou P, Razavi SM, Solaymani-Dodaran M, Vakili M, Asadi-Lari M. Demographic and prognostic factors of 455 patients with acute leukemia admitted to two referral hospitals in Tehran-Iran during Ten years (2001-2011). Iranian J Cancer Prev 2012; 5: 157-63.
10. Ziaei JE. High frequency of acute promyelocytic leukemia in northwest Iran. Asian Pac J Cancer Prev 2004; 5: 188-9.
11. Akbarzadeh Baghban A, Hosseinifard H, Baghestani AR, Ahmadi S, Rezaei Tavirani M. Factors that affecting survival of patients with acute myeloid leukemia. Koomesh 2016: 17: 596-602. [In Persian]
12. Rauscher GH, Sandler DP, Poole C, Pankow J, Mitchell B, Bloomfield CD, et al. Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol 2002; 156: 517-26. [DOI:10.1093/aje/kwf075]
13. Padilha SL, Dos Santos Souza EJ, Matos MCC, Domino NR. Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná. Rev Bras Hematol Hemoter 2015; 37: 21-7. [DOI:10.1016/j.bjhh.2014.11.008]
14. Ribera JM, Oriol A. Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 2009; 23: 1033-42. [DOI:10.1016/j.hoc.2009.07.002]
15. Juliusson G, Antunovic P, Derolf Å, Lehmann S, Möllgård L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia registry. Blood 2009; 113: 4179-87. [DOI:10.1182/blood-2008-07-172007]
16. Ma H, Sun H, Sun X. Survival improvement by decade of patients aged 0–14 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep 2014; 4: 4227. [DOI:10.1038/srep04227]
17. Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009; 113: 1408-11. [DOI:10.1182/blood-2008-06-164863]
18. Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002; 100: 1957-64. [DOI:10.1182/blood-2002-02-0395]
19. Abrisqueta P, Pereira A, Rozman C, Aymerich M, Giné E, Moreno C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Blood 2009; 114: 2044-50. [DOI:10.1182/blood-2009-04-214346]
20. Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009; 113: 1408-11. [DOI:10.1182/blood-2008-06-164863]
21. Zareifar S, Almasi-Hashiani A, Karimi M, Tabatabaee SH, Ghiasvand R. Survival rate of pediatric leukemia and its determinants. Koomesh 2012; 14: 13-9. [In Persian]


XML   Persian Abstract   Print



Volume 23, Issue 2 (Scientific Journal of Kurdistan University of Medical Sciences 2018) Back to browse issues page